在LIBERTY Asthma QUEST研究中,Dupilumab可降低中重度哮喘患者的严重恶化并改善肺功能,无论基线支气管扩张剂可逆性如何

I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper
{"title":"在LIBERTY Asthma QUEST研究中,Dupilumab可降低中重度哮喘患者的严重恶化并改善肺功能,无论基线支气管扩张剂可逆性如何","authors":"I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":104393,"journal":{"name":"B15. IMMUNOTHERAPY FOR LUNG DISEASE","volume":"349 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study\",\"authors\":\"I. Pavord, M. Castro, K. Rabe, N. Hanania, A. Papi, J. Fitzgerald, M. Rice, P. Rowe, Y. Lu, N. Amin, H. Staudinger, N. Graham, A. Teper\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":104393,\"journal\":{\"name\":\"B15. IMMUNOTHERAPY FOR LUNG DISEASE\",\"volume\":\"349 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B15. IMMUNOTHERAPY FOR LUNG DISEASE\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B15. IMMUNOTHERAPY FOR LUNG DISEASE","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a2624","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Dupilumab Reduces Severe Exacerbations and Improves Lung Function Regardless of Baseline Bronchodilator Reversibility in Patients with Uncontrolled Moderate-to-Severe Asthma Enrolled in the LIBERTY ASTHMA QUEST Study Preservation of Lung Function Observed in a Phase 3 Randomized Controlled Trial of Tocilizumab for the Treatment of Early Systemic Sclerosis Oral TORC1 Inhibitor Dactolisib Enhances Immune Function and Reduces the Incidence of Respiratory Tract Infections in Elderly Subjects with Asthma Benralizumab for Chronic Obstructive Pulmonary Disease: Results of the Phase III GALATHEA Trial The Impact of Tezepelumab on Hospitalization and Emergency Department Visits in Patients with Severe Uncontrolled Asthma: Results from the Pathway Phase 2b Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1